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ABSTRACT
To reconstruct the evolutionary dynamics of the 2019 novel coronavirus recently causing an outbreak in 
Wuhan, China, 52 SARS-CoV-2 genomes available on 04 February 2020 at GISAID were analysed.
The two models used to estimate the reproduction number (coalescent-based exponential growth and a 
birth-death skyline method) indicated an estimated mean evolutionary rate of 7.8 x 10-4 subs/site/year 
(range 1.1x10-4–15x10-4) and a mean tMRCA of the tree root of 73 days. 
The estimated R value was 2.6 (range 2.1-5.1), and increased from 0.8 to 2.4 in December 2019. The 
estimated mean doubling time of the epidemic was between 3.6 and 4.1 days.
This study proves the usefulness of phylogeny in supporting the surveillance of emerging new infections 
even as the epidemic is growing.
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INTRODUCTION
On 30 January 2020, the World Health Organisation (WHO) declared that the outbreak of an infection due 
to a novel coronavirus (SARS-CoV-2) was a “Public Health Emergency of International Concern” 
(https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-
international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-
coronavirus-(2019-nCoV)). Emerging as a human pathogen in the Chinese city of Wuhan, SARS-CoV-2 
(https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-
ncov.pdf?sfvrsn=20a99c10_4) has caused a widespread outbreak of febrile respiratory illness and, as of 13 
February 2020, there were 60,349 confirmed cases (including 527 outside mainland China) and a total of 
1,360 fatalities
(https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9e
cf6).
Belonging to the β-coronavirus genus of the Coronaviridae family, SARS-CoV-2 is closely related to SARS-
CoV as there is >70% nucleotide similarity in their approximately 30 kb long genomes.1 A recent study has 
supported the view that, like other β-coronaviruses causing human infections such as SARS-CoV and MERS-
CoV, SARS-CoV-2 originated from bats, and reported 96% genomic identity with a previously detected 
SARS-like bat coronavirus.2,3 However, it remains unclear whether the spillover also involved a different 
intermediary animal host.
In the case of such an epidemic, it is important to make as reliable as possible estimate of the basic 
reproductive number (R0, the number of cases generated from a single infected person) and the dynamics 
of transmission. The aim of this study was to investigate the temporal origin, rate of viral evolution and 
population dynamics of SARS-CoV-2 using 52 full genomes of viral strains sampled in different countries on 
known sampling dates available at the moment when study was performed.
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MATERIALS AND METHODS
Sequence data set
The analysis was based on 52 SARS-CoV-2 sequences publicly available at GISAID (Global Initiative on 
Sharing All Influenza Data) on 4 February 2020 (https://www.gisaid.org/). The accession IDs, sampling dates 
and locations are summarized in Table S1.
The sequences were aligned using the ClustalW Multiple Alignment program included in the accessory 
application of Bioedit software, manually controlled, and cropped to a final length of 29,774 bp using 
BioEdit v. 7.2.6.1 (http://www. mbio.ncsu. edu/ bioedit/ bioedit. html).
Phylodynamic analysis
The simplest evolutionary model best fitting the sequence data was selected using software JmodelTest 
v.2.1.7 software,4 and proved to be the Hasegawa-Kishino-Yano (HKY) model.
The virus' phylogeny, evolutionary rates, times of the most recent common ancestor (tMRCA) and 
demographic growth were co-estimated in a Bayesian framework using a Markov Chain Monte Carlo 
(MCMC) method implemented in v.1.8.4 of the BEAST package.5
Different coalescent priors and molecular clock models (constant population size, exponential growth, and 
a Bayesian skyline plot, BSP) were tested using strict and relaxed molecular clock models. Given the large 
credibility interval and high level of uncertainty due to very close sampling dates, all the estimates were 
made using days as the unit of time and a normal prior with substitution rates obtained from our 
preliminary estimates (mean rate 2.2 x 10-6 subs/site/day, with a standard deviation of 1.1 x 10-6).
The MCMC analysis was run until convergence with sampling every 100,000 generations. Convergence was 
assessed by estimating the effective sampling size (ESS) after 10% burn-in using Tracer v.1.7 software 
(http://tree.bio.ed.ac.uk/software/tracer/), and accepting ESS values of 300 or more. The uncertainty of 
the estimates is indicated by 95% highest marginal likelihoods estimated6 by path sampling/stepping stone 
methods.7
The final trees were summarised by selecting the tree with the maximum product of posterior probabilities 
(pp) (maximum clade credibility or MCC) after a 10% burn-in using Tree Annotator v.1.8.4 (included in the 
BEAST package), and were visualised using FigTree v.1.4.2 (http://tree.bio.ed.ac.uk/software/figtree/).
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The basic reproductive number (R0) was calculated on the basis of the exponential growth rate (r) using the 
equation R0=rD+1, where D is the average duration of infectiousness estimated as described below.8 The 
doubling time of the epidemic was directly estimated setting the tree prior to the coalescent exponential 
growth analysis with doubling time parameterization.
Birth-Death Skyline estimates of the effective reproductive number (Re)
The birth-death skyline model implemented in Beast 2.48 was used to infer changes in the effective 
reproductive number (Re), and other epidemiological parameters such as the death/recovery rate (δ), the 
transmission rate (λ), the origin of the epidemic, and the sampling proportion (ρ).9 Given that the samples 
were collected during a short period of time, a “birth-death contemporary” model was used.
The analyses were based on the previously selected HKY substitution model and the evolutionary rate was 
set to the value of 8.0 x 10-4 subs/site/year, which corresponds to the mean substitution rate estimated 
using a relaxed clock under the exponential coalescent model as transformed into units per year.
For the birth-death analysis, one and two intervals and a log-normal prior for Re, with a mean (M) of 0.0 
and a variance (S) of 1.0 were chosen, which allows the Re values to change between <1 (0.193) to >5. A 
normal prior with M=48.7 and S=15 (corresponding to a 95% interval from 24.0 to 73.4) was used for the 
rate of becoming uninfectious. These values are expressed as units per year and reflect the inverse of the 
time of infectiousness (5.3-19 days, mean 7.5) according to the serial interval estimated by Qun Li et al.10 
Sampling probability (ρ) was estimated assuming a prior Beta (alpha=1.0 and beta=999), corresponding to a 
minority of the sampled cases (between 10-5 to 10-3). The origin of the epidemic was estimated using a 
normal prior with M=0.1 and S=0.05 in units per year.
The MCMC analyses were run for 30 million generations and sampled every 3,000 steps.
Convergence was assessed on the basis of ESS values (ESS >200). Uncertainty in the estimates was indicated 
by 95% highest posterior density (95%HPD) intervals.
The mean growth rate was calculated on the basis of the birth and recovery rates (r=λ-δ), and the doubling 
time was estimated by the equation: doubling time=ln(2)/r.11
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RESULTS
The sequence analyses under a relaxed (uncorrelated log-normal) or strict molecular clock showed that the 
former performed better as assessed by using BF with path sampling (PS) and stepping stone sampling (SS) 
(strict vs. relaxed molecular clock BF(PS)=-8.66 and BF(SS)=-10.7 for relaxed clock). Comparison of the 
different demographic models showed that the BSP model best fitted the data (BSP vs. exponential growth 
BF(PS)= 7.3 and BF(SS)= 8.78 for BSP; BSP vs. constant population size BF(PS)= 7.3and BF(SS)= 8.78 for BSP).
The estimated mean evolutionary rate was 2.15 x 10-6 subs/site/day (95% HPD: 3.22 x 10-7–4.18 x 10-6), 
corresponding to 7.8 x 10-4 subs/site/year (95% HPD: 1.1 x 10-4–15 x 10-4).
The estimated mean tMRCA corresponding to the root of the tree dated 73 days before the end of January 
2020 (95%HPD: 32.5–142.3), corresponding to 18 November 2019 (95%HPD: 10 September 2019-28 
December 2019).
The Bayesian tree showed three main significant clades. The largest clade (pp=0.84) encompassed 10 
sequences and consisted of two significant sub-clades (pp=0.9 and pp=1). Overall, this cluster included 
fewer recent isolates than the other two clusters, and dated back to 47.5 days ago (95% HPD: 25.5-76.6), 
corresponding to 13 December 2019. The second (pp=0.99) and third significant clusters (pp=0.95) dated 
back to 29.2 (95% HPD: 0.7-47.45) and 21.9 (95% HPD 3.6-54.7) days ago, corresponding to 01-08 January 
2020.
The Bayesian skyline plot showed a rapid increase in the number of infections in a period between about 45 
and 30 days before the end of January 2020 (Fig.1, part A).
The IDs and available data of the sequences involved in the clades are shown in Table S1.
The estimated growth rate under the exponential growth model was 0.218 days-1, corresponding to an R0 
estimation of 2.6 (credibility interval: 2.1-5.1). The direct estimation of the doubling time of the epidemic 
gave a mean 3.6 days (varying from 1.0 to 7.7). Figure 1 (part B) shows the Bayesian birth-death skyline plot 
of the Re estimates with 95%HPD, and indicates that Re increased from <1 (mean 0.8, 95%HPD: 0.3-1.3) to a 
mean value of 2.4 (95%HPD: 1.5-3.5) in December 2019, and has since remained at this value. The 
estimation allowing a single Re gave a mean value of 1.85 (95%HPD: 1.37-2.4).
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Table 1 shows the parameters estimated using the birth-death skyline plot. The epidemic originated an 
estimated mean 3.7 months (credibility interval 3-4) before the present (BP), corresponding to October-
November 2019, before the root tree (3.6 months BP). The estimated recovery rate (the time to becoming 
non-infectious) was 7.3 days (CI 4.7-16.5 days), whereas the transmission rate (λ) increased from 40.5 to 
112.4 in units per year in December 2019. On the basis of these values, the growth rate in the second 
period is r=0.17 (0.16-0.19), corresponding to a mean doubling time of 4.1 days (range 3.9-4.3).
Page 7 of 15 Journal of Medical Virology
DISCUSSION
The SARS-CoV-2 epidemic is unique in the history of human infectious diseases not only because it is caused 
by a novel virus, but also because of the immediate availability of epidemiological and genomic data (the 
first entire genome was published on 24 December 2019). The prompt availability of research data on 
internet platforms such as the GISAID has allowed us and other research groups to make a phylogenetic 
reconstruction of the origin of SARS-CoV-2 and to share these findings with other scientists.
The temporal reconstruction of the SARS-CoV-2 phylogeny obtained in the present study is in line with 
previous estimates and suggests that the epidemic originated between October and November 2019, 
several weeks before the first cases were described. This was confirmed by means of coalescent analysis 
and the birth-death method of estimating the origin of the epidemic. The estimated evolutionary rate is 
also in line with that of SARS and MERS viruses,12,13 and the recent estimates concerning SARS-CoV-2 
(http://virological.org/t/phylodynamic-analysis-67-genomes-08-feb-2020/356).
One of the most important epidemiological parameters when monitoring an epidemic is R0 (i.e. the number 
of secondary cases induced by a single infected individual in a totally susceptible population) because it is 
fundamental to assess the potential spread of a micro-organism. Its value changes during an epidemic 
being called the effective reproduction number (Re). R0 is usually estimated on the basis of the growth rate 
of the number of cases. The available epidemiological estimates of SARS-CoV-2 R0 range from 2.2 to 2.9, 
although they changed from 1.4 to >7 during the first phases of the epidemic.10,14
Recently developed evolutionary models have made it possible to estimate epidemiological parameters on 
the basis of phylogenesis,9,15 and a coalescent and a birth-death methods were used to estimate R0 and the 
changes in the Re of the SARS-CoV-2 epidemic during a short period of time. This has allowed us to make a 
preliminary estimate that mean R0 from the beginning of the epidemic to the first days of February 2020 
was 2.2 (range 3.6-5.8), and the birth-death skyline analysis showed an increase in Re from <1 to 2.4 (CI 1.5-
3.5) during December 2019. This agrees with the BSP analysis showing an increase in the number of 
infections in the same period of time. Commonly, the Re decreases during an epidemic because the 
decrease of the number of susceptible individuals. However, an increase in Re could be due to an increase 
in the transmissibility of the virus or in the contact rates within the population.16 It is therefore possible to 
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hypothesize, on the basis of our data, that the first passage of the virus from animal to human occurred 
through rather inefficient and still unknown transmission modes causing relatively few cases in the early 
times (before December). In December, the virus acquired more efficient mode of human-to-human 
transmission (i.e. through droplets), causing an exponential growth also detected by the skyline.
On the same basis, the estimated epidemic doubling time was 3.6 days with a credibility interval between 1 
to 7 days. We also tried to calculate it on the basis of the transmission (λ) and recovery rate (δ) estimated 
using the birth-death model, which lead to an estimated mean doubling time of 4.1 days, with the most 
probable values falling between 3.9 and 4.3 days. Previous studies have suggested that the doubling time 
during the early phases of the epidemic was about 7.4 days.10 The difference in the estimate here obtained, 
may be due to the increased epidemic growth rate observed during the last days of January, or the initial 
delay in recognising and reporting new cases.
This preliminary study has some limitations. The R values and doubling times were estimated 
phylogentically using all of the whole genomes available in a public database at the time the study was 
carried out (https://www.gisaid.org/). Given the small number of sequences and the relatively short 
sampling period, the credibility intervals are wide and limit the precision of the estimates. Moreover, the 
analysis included isolates collected outside mainland China as it is assumed that they all belong to the same 
epidemic originating in Wuhan.
Serial intervals were used to estimate the duration of infectiousness, although we do not yet have any 
information concerning the possible existence and duration of a latent (pre-infectious) period that would 
contribute to the serial interval.
More detailed and accurate analyses can be made when a larger number of genomes and more precise 
data on the infectious period become available. However, although the R0 calculated on the basis of the 
direct observation of the number of infected individuals may be affected by omissions or delayed 
notifications of cases,17 a phylogenetic estimate of the same parameter may be more reliable.
This became particularly evident recently (on February 12, 2020) when the change in diagnosis 
classification led to a sudden increase in the reported cases by Hubei, China 
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(https://myemail.constantcontact.com/COVID-19-Updates---Feb-
12.html?soid=1107826135286&aid=Kdg8a0rBTAk).
In conclusion, these results allowed us to make a phylogenetic estimate of the R0 of SARS-CoV-2 infection 
that is similar to that obtained using conventional epidemiological methods18 (https://www.who.int/news-
room/detail/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-
emergency-committee-regarding-the-outbreak-of-novel-coronavirus-( SARS-CoV-2), and a possibly shorter 
estimated doubling time of the number of subjects involved at least during the early phases of the 
epidemic. They also support the usefulness of phylodynamic as an important complement to classic 
approaches to the surveillance and monitoring of an emerging infection, even during the course of an 
epidemic.
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FIGURE LEGEND
Fig. 1. Part A: Bayesian Skyline plot of the SARS-CoV-2 outbreak. The Y axis indicates Ne and X axis shows 
the time in year units (0=January 30; 18.2 days; 36.5 days; 54.7 days and 73 days before). The thick solid 
line represents the median value of the estimates, and the grey area the 95% HPD. Part B: Birth-death 
skyline plot of the SARS-CoV-2 outbreak allowing two Re intervals. The curve and the orange area show the 
mean Re values and their 95% confidence intervals. The Y and X axes respectively represent R values and 
time in days.
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 Fig. 1. Part A: Bayesian Skyline plot of the SARS-CoV-2 outbreak. The Y axis indicates Ne and X axis shows 
the time in year units (0=January 30; 18.2 days; 36.5 days; 54.7 days and 73 days before). The thick solid 
line represents the median value of the estimates, and the grey area the 95% HPD. Part B: Birth-death 
skyline plot of the SARS-CoV-2 outbreak allowing two Re intervals. The curve and the orange area show the 
mean Re values and their 95% confidence intervals. The Y and X axes respectively represent R values and 
time in days. 
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Table 1. Epidemiological parameters estimated by Birth-death skyline analysis.
Parameter mean estimate 95%HPDe Low 95%HPD Up
Re1
a 0.8 0.29 1.3
Re2 2.4 1.5 3.5
origin 0.304 0.24 0.36
become uninfectiousb 49.8 22.1 78.3
birth1c 40.46 7.9 73.8
birth2 112.4 82.3 142.9
rhod 0.0044 0.00087 0.0086
tree-root tMRCA 0.296 0.24 0.35
a Recovery rate
b Transmission rate
c Effective reproductive number
d Sampling probability
e High posterior density
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